Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease

European Journal of Medicinal Chemistry

Volumn 80, Issue , 2014, Pages 175-183

  Mourtas, Spyridon ^a   Lazar, Adina N ^b,c   Markoutsa, Eleni ^a   Duyckaerts, Charles ^b,c   Antimisiaris, Sophia G ^a,d  

^a UNIVERSITY OF PATRAS   (Greece)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^d INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

Author keywords

Amyloid; Curcumin; Liposome; Multifunctional; Nanoparticle; Targeting

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CURCUMIN; DPS PEG2000 CURC NANOLIPOSOME; LIPID; LIPOSOME; MONOCLONAL ANTIBODY; NANOCARRIER; THIOFLAVINE; TRANSFERIN ANTIBODY; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); MACROGOL DERIVATIVE; NANOPARTICLE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CONTROLLED STUDY; DRUG CONJUGATION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; BRAIN; CHEMISTRY; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; TRANSPORT AT THE CELLULAR LEVEL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CURCUMIN; HUMANS; LIPOSOMES; MOLECULAR TARGETED THERAPY; NANOPARTICLES; PEPTIDE FRAGMENTS; POLYETHYLENE GLYCOLS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY;

EID: 84899518848     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.04.050     Document Type: Article

References (34)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR fourth ed. 2000 American Psychiatric Association Washington, DC
2. B.T. Hyman, C.H. Phelps, T.G. Beach, E.H. Bigio, N.J. Cairns, M.C. Carrillo, D.W. Dickson, C. Duyckaerts, M.P. Frosch, E. Masliah, S.S. Mirra, P.T. Nelson, J.A. Schneider, D.R. Thal, B. Thies, J.Q. Trojanowski, H.V. Vinters, and T.J. Montine National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease Alzheimer's & Dementia: the Journal of the Alzheimer's Association 8 2012 1 13
3. J. Hardy Testing times for the "amyloid cascade hypothesis" Neurobiology of Aging 23 2002 1073 1074 (Pubitemid 35447788)
4. T. Iwatsubo, A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina, and Y. Ihara Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43) Neuron 13 1994 45 53
5. D.J. Selkoe The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease Trends in Cell Biology 8 1998 447 453
6. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiological Reviews 81 2001 741 766 (Pubitemid 32267077)
7. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D.P. Holt, M. Bergström, I. Savitcheva, G.F. Huang, S. Estrada, B. Ausén, M.L. Debnath, J. Barletta, J.C. Price, J. Sandell, B.J. Lopresti, A. Wall, P. Koivisto, G. Antoni, C.A. Mathis, and B. Långström Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Annals of Neurology 55 2004 306 319 (Pubitemid 38269583)
8. D. Yanagisawa, T. Amatsubo, S. Morikawa, H. Taguchi, M. Urushitani, N. Shirai, K. Hirao, A. Shiino, T. Inubushi, and I. Tooyama In vivo detection of amyloid beta deposition using (1)F magnetic resonance imaging with a (1)F-containing curcumin derivative in a mouse model of Alzheimer's disease Neuroscience 184 2011 120 127
9. M. Koronyo-Hamaoui, Y. Koronyo, A.V. Ljubimov, C.A. Miller, M.K. Ko, K.L. Black, M. Schwartz, and D.L. Farkas Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model Neuroimage 54 Suppl. 1 2011 S204 S217
10. I. Lee, J. Yang, J.H. Lee, and Y.S. Choe Synthesis and evaluation of 1-(4-[(18)F] fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for beta-amyloid plaque imaging Bioorganic & Medicinal Chemistry Letters 21 2011 5765 5769
11. A.N. Lazar, S. Mourtas, I. Youssef, C. Parizot, A. Dauphin, B. Delatour, S.G. Antimisiaris, and C. Duyckaerts Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease Nanomedicine: Nanotechnology, Biology, and Medicine 9 2013 712 721
12. A.N. Begum, M.R. Jones, G.P. Lim, T. Morihara, P. Kim, D.D. Heath, C.L. Rock, M.A. Pruitt, F. Yang, B. Hudspeth, S. Hu, K.F. Faull, B. Teter, G.M. Cole, and S.A. Frautschy Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease The Journal of Pharmacology and Experimental Therapeutics 326 2008 196 208 (Pubitemid 351872144)
13. K. Ono, K. Hasegawa, H. Naiki, and M. Yamada Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro Journal of Neuroscience Research 2004,Mar 15 742 750 (Pubitemid 38296087)
14. F. Yang, G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, S.S. Ambegaokar, P.P. Chen, R. Kayed, C.G. Glabe, S.A. Frautschy, and G.M. Cole Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo The Journal of Biological Chemistry 280 2005 5892 5901 (Pubitemid 40280072)
15. S.G. Antimisiaris, P. Kallinteri, D.G. Fatouros, Liposomes, and Drug Delivery S.C. Gad, Pharmaceutical Manufacturing Handbook: Production and Processes 2007 John Wiley & Sons, Inc. Hoboken, NJ, USA 443 535
16. R.I. Jolck, L.N. Feldborg, S. Andersen, S.M. Moghimi, and T.L. Andresen Engineering liposomes and nanoparticles for biological targeting Advances in Biochemical Engineering/Biotechnology 125 2011 251 280
17. L. Costantino, G. Tosi, B. Ruozi, L. Bondioli, M.A. Vandelli, and F. Forni Colloidal systems for CNS drug delivery Progress in Brain Research 180 2009 35 69
18. S. Mourtas, M. Canovi, C. Zona, D. Aurilia, A. Niarakis, B. La Ferla, M. Salmona, F. Nicotra, M. Gobbi, and S.G. Antimisiaris Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide Biomaterials 32 2011 1635 1645
19. S. Mourtas, D. Gatos, V. Kalaitzi, C. Katakalou, and K. Barlos S-4-Methoxytrityl mercapto acids: synthesis and application Tetrahedron Letters 42 2001 6965 6967 (Pubitemid 32830931)
20. J.C. Dittmer, R.L. Lester, and A Simple Specific spray, for the detection of phospholipids on thin-layer chromatograms Journal of Lipid Research 15 1964 126 127
21. J.C.M. Stewart Colorimetric determination of phospholipids with ammonium ferro thiocyanate Analytical Biochemistry 104 1980 10 14 (Pubitemid 10045896)
22. E. Markoutsa, K. Papadia, A. Giannou, M. Spella, A. Cagnotto, M. Salmona, G.T. Stathopoulos, and S.G. Antimisiaris Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies Pharmaceutical Research 2014 (in press)
23. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathologica 82 1991 239 259
24. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle, and L. Berg The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
25. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease The national Institute on aging, and Reagan Institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease Neurobiology of Aging 18 4 Suppl. 1997 S1 S2
26. C. Manzoni, L. Colombo, M. Messa, A. Cagnotto, L. Cantu, E. Del Favero, and M. Salmona Overcoming synthetic Aβ peptide aging: a new approach to an age old problem Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 16 2009 71 80
27. B. Weksler, I.A. Romero, and P.-O. Couraud The hCMEC/D3 cell line as a model of the human blood brain barrier Fluids and Barriers of the CNS 10 2013 16 26
28. E. Markoutsa, K. Papadia, C. Clemente, O. Flores, and S.G. Antimisiaris Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells European Journal of Pharmaceutics and Biopharmaceutics 81 2012 49 56
29. R.B. Greenwald, C.W. Gilbert, A. Pendri, C.D. Conover, J. Xia, and A. Martinez Water soluble taxol: 2′-poly(ethyleneglycol) ester prodrugs-design and in vivo effectiveness Journal of Medicinal Chemistry 39 1996 424 431
30. A. Mukherjee, T.K. Prasad, N.M. Rao, and R. Banerjee Haloperidol- associated stealth liposomes. A potent carrier for delivering genes to human breast cancer cells The Journal of Biological Chemistry 280 2005 15619 15627 (Pubitemid 40616679)
31. M. Taylor, S. Moore, S. Mourtas, A. Niarakis, F. Re, C. Zona, B. LaFerla, F. Nicotra, M. Masserini, S.G. Antimisiaris, M. Gregori, and D. Allsop Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide Nanomedicine: Nanotechnology, Biology, and Medicine 7 2011 541 550
32. E. Markoutsa, G. Pampalakis, A. Niarakis, I.A. Romero, B. Weksler, P.-O. Couraud, and S.G. Antimisiaris Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 77 2011 265 274
33. S.A. DeFrees, L. Phillips, L. Guo, and S. Zalipsky Sialyl Lewis × liposomes as a multivalent ligand and inhibitor of E-selectin mediated cellular adhesion Journal of the American Chemical Society 118 1996 6101 6104 (Pubitemid 26236843)
34. S. Zalipsky, N. Mullah, J.A. Harding, J. Gittelman, L. Guo, and S.A. DeFrees Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains Bioconjugate Chemistry 8 1997 111 118 (Pubitemid 27153283)